Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 19, Issue 5, 2001, Pages 1326-1335

  Brundage, M D ^a   Feldman Stewart, D ^a   Cosby, R ^a   Gregg, R ^a   Dixon, P ^a   Youssef, Y ^a   Davies, D ^a   Mackillop, W J ^a  

^a KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOCTOR PATIENT RELATION; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SATISFACTION; PHASE 1 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

EID: 0035281919     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.5.1326     Document Type: Article

References (43)

1. Unresected Stage III non-small-cell lung cancer
2. Trading treatment toxicity for survival in locally advanced lung cancer
3. Decision analysis in locally advanced non-small cell lung cancer: Is it useful?
4. Evaluation standards for patient decision supports
5. A new international staging system for non-small cell lung cancer
6. Locally advanced non-small cell lung cancer: Do we know the questions?
7. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
8. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidemoid bronchogenic carcinoma
9. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
10. RTOG 88-08 and ECOG 4588: Preliminary analysis of a phase Ill trial in regionally advanced, unresectable non-small-cell lung cancer
11. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology
12. Chemotherapy and radiation in the nonoperative management of stage III non-small-cell lung cancer: The right chemotherapy works in the right setting
13. The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer
14. Controversies in the management of non-small cell lung cancer: The results of an expert surrogate study
15. Does knowledge guide practice? Another look at the management of non-small cell lung cancer
16. Variation in the management and outcome of non-small cell lung cancer in Ontario
17. Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation
18. Using a treatment-tradeoff methods to elicit preferences for the treatment of locally advanced non-small cell lung cancer
19. The Royal College of Radiologists Clinical Oncology Information Network: Guidelines on the non-surgical management of lung cancer
20. Informed consent: Why are its goals imperfectly realized?
21. Cancer patients' perceptions of their disease and its treatment
22. Do doctors know when their patients don't? A survey of doctor-patient communication in lung cancer
23. Validation of a decisional conflict scale
24. How to improve Bayesian reasoning without instruction: Frequency formats
25. Decision making during serious illness: What role do patients really want to play?
26. Cancer treatment decisions: Patients' desires for participation and information
27. Information and decisionmaking preferences of men with prostate cancer
28. Relationship between preferences for decisional control and illness information among women with breast cancer: A quantitative and qualitative analysis
29. Cancer patients: Their desire for information and participation in treatment decisions
30. Whose utilities for decision analysis?
31. Fallacy of the five-year survival in lung cancer
32. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: Descriptive study based on scripted interviews
33. Use of vinorelbine in non-small cell lung cancer
34. Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only: A multicenter randomized phase III trial
35. Reasoning the fast and frugal way: Models of bounded rationality
36. Direct inference, probability, and a conceptual gulf in risk communication
37. Readability of American Cancer Society patient education literature
38. Some life and death consequences of perceived control
39. Differentiation and consolidation: Theory of human decision making - A frame of reference for the study of pre- and post-decision processes
40. On the elicitation of preferences for alternative therapies
41. Eliciting preferences for alternative cancer drug treatments: The influence of framing, medium, and rater variables